-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Pacmilimab in Adenocarcinoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Pacmilimab in Adenocarcinoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Pacmilimab in Adenocarcinoma Drug Details: CX-072 is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – MDK-701 in Solid Tumor
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. MDK-701 in Solid Tumor Drug Details: MDK-701 is under development for the treatment of solid...
-
Product Insights
Interleukin 7 Receptor Subunit Alpha (CDw127 or CD127 or IL7R) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Interleukin 7 Receptor Subunit Alpha Pipeline Drugs Market Report Overview Interleukin-7 receptor is a protein found on the surface of cells. It acts as a receptor for thymic stromal lymphopoietin (TSLP) and plays an important role in T-cell acute lymphoblastic leukemia, multiple sclerosis, rheumatoid arthritis, and juvenile idiopathic arthritis. The Interleukin 7 Receptor Subunit Alpha pipeline drugs market research report provides comprehensive information on the Interleukin 7 Receptor Subunit Alpha targeted therapeutics, complete with analysis by indications, stage of development,...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – MDK-701
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry MDK-701 Drug Details MDK-701 is under development for the treatment of solid tumors. The...
-
Product Insights
Osteonecrosis Global Clinical Trials Review, H1, 2016
GlobalData's clinical trial report, “Osteonecrosis Global Clinical Trials Review, H1, 2016" provides an overview of Osteonecrosis clinical trials scenario. This report provides top line data relating to the clinical trials on Osteonecrosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...